|
ACTR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.163350E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.916100E-03 |
| Normal-vs-Stage2 |
9.592800E-01 |
| Normal-vs-Stage3 |
5.608400E-01 |
| Normal-vs-Stage4 |
9.887400E-01 |
| Stage1-vs-Stage2 |
1.680160E-01 |
| Stage1-vs-Stage3 |
2.584500E-02 |
| Stage1-vs-Stage4 |
3.028000E-01 |
| Stage2-vs-Stage3 |
6.397600E-01 |
| Stage2-vs-Stage4 |
9.873600E-01 |
| Stage3-vs-Stage4 |
7.389600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.601700E-02 |
| Normal-vs-AfricanAmerican |
2.798600E-01 |
| Normal-vs-Asian |
9.724200E-01 |
| Caucasian-vs-AfricanAmerican |
6.952400E-01 |
| Caucasian-vs-Asian |
5.545600E-01 |
| AfricanAmerican-vs-Asian |
6.609200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.502600E-03 |
| Normal-vs-Female |
9.038100E-02 |
| Male-vs-Female |
6.00729999999938E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.202000E-02 |
| Normal-vs-Extreme_Weight |
4.972600E-04 |
| Normal-vs-Obese |
9.457800E-01 |
| Normal-vs-Extreme_Obese |
2.425600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.879000E-01 |
| Normal_Weight-vs-Obese |
1.603160E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.944800E-01 |
| Extreme_Weight-vs-Obese |
6.498500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.917600E-01 |
| Obese-vs-Extreme_Obese |
2.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.735600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.898800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.778020E-02 |
| Normal-vs-Age(81-100Yrs) |
1.082130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.245000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.528300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.522000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.379700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.051600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.597400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.095300E-03 |
| Normal-VS-Type2 PRCC |
2.124400E-01 |
| Normal-VS-KIRP CIMP |
1.309660E-02 |
| Normal-VS-Unclassified PRCC |
4.105400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.155600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.35169999982266E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.529960E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.378510E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.898400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.499500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.561100E-03 |
| Normal-vs-N1 |
9.887900E-02 |
| Normal-vs-N2 |
8.808800E-01 |
| N0-vs-N1 |
2.820600E-03 |
| N0-vs-N2 |
3.924400E-01 |
| N1-vs-N2 |
4.456200E-01 |
|
|
